Csenge Advisory Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Csenge Advisory Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.23M	Buy	7,753 +4,585	+145%	+$620K	0.05%	278
2026 Q1	$405K	Buy	+3,168	New	+$395K	0.02%	485
2024 Q4	–	Sell	-10,623	Closed	-$1.05M	–	769
2024 Q3	$1.05M	Buy	+10,623	New	+$1.04M	0.05%	259
2024 Q2	–	Sell	-2,186	Closed	-$207K	–	761
2024 Q1	$207K	Buy	+2,186	New	+$203K	0.01%	669
2022 Q2	–	Sell	-10,463	Closed	-$940K	–	690
2022 Q1	$940K	Buy	+10,463	New	+$966K	0.07%	232
2019 Q2	–	Sell	-19,247	Closed	-$1.74M	–	221
2019 Q1	$1.74M	Sell	19,247 -257	-1%	-$21.9K	0.6%	31
2018 Q4	$1.4M	Buy	19,504 +2,486	+15%	+$200K	0.51%	40
2018 Q3	$1.27M	Buy	17,018 +329	+2%	+$31.9K	0.5%	41
2018 Q2	$1.59M	Buy	16,689 +399	+2%	+$36.7K	0.58%	41
2018 Q1	$1.43M	Sell	16,290 -854	-5%	-$78K	0.5%	49
2017 Q4	$1.46M	Sell	17,144 -1,738	-9%	-$146K	0.52%	48
2017 Q3	$1.63M	Buy	+18,882	New	+$1.51M	0.65%	33

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Csenge Advisory Group's XBI Position: Q2 2026 in Review

Csenge Advisory Group increased its State Street SPDR S&P Biotech ETF (XBI) stake by 145% in Q2 2026, buying an estimated $620K and bringing the position to 7,753 shares worth $1.23M. The position accounts for 0.05% of the portfolio, ranked #278.

Csenge Advisory Group first reported a position in XBI in Q3 2017 and has held it in 12 quarters since. The position peaked at $1.74M in Q1 2019. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Csenge Advisory Group held 7,753 shares of State Street SPDR S&P Biotech ETF worth $1.23M as of Q2 2026.
Csenge Advisory Group bought 4,585 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $620K.
State Street SPDR S&P Biotech ETF made up 0.05% of Csenge Advisory Group's portfolio in Q2 2026, its #278 holding.
Csenge Advisory Group first reported a position in State Street SPDR S&P Biotech ETF in Q3 2017 and has held it in 12 quarters since.
Csenge Advisory Group's State Street SPDR S&P Biotech ETF position peaked at $1.74M in Q1 2019.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Csenge Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.